| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | 10x Genomics Powering researchers’ insights with innovative single cell, spatial biology, & in situ tools. 🧬🔬 Cells are the basic unit of life. They power everything we do, and unlocking their secrets is the key to advancing our knowledge of every facet of biology, from development to disease. Our single cell, spatial, and in situ tools enable researchers to answer pressing questions about cells and their functional contributions to oncology, immunology, neuroscience, and much more—as evidenced by more than 5,500 publications citing our technology. We are dedicated to building the best products, delivering the best customer experience, and creating the best team … Type: | 0 | 0 | 0 | 2,033 |
 |  1928 Diagnostics Where complex data turns into actionable results. 1928 Diagnostics offers a bioinformatics analytics platform for infection control. Using sequence data, 1928 contributes to the fight against infections by identifying and characterizing pathogens to assist in tracking, controlling, and preventing outbreaks. Our innovation offers a solution to control the spread of infections and save the power of antibiotics, thereby improving world health and saving costs for healthcare systems. bioinformatics, software, antibiotic resistance, infection diagnostics, microbiology, MRSA, next generation sequencing, whole genome sequencing, outbreak surveillance, software-as-a-service, clinical bacteriology, molecular biology, and genomics Type: | 1 | 1 | 0 | 13 |
 | 23andMe 23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. The platform also powers … Type: | 20 | 3 | 4 | 888 |
 | 2BMonthly The Global Biocontrol & Biostimulants E-Newsletter DunhamTrimmer LLC (International Biocontrol Specialists) and New Ag International (The World’s Leading Publication on High Tech Agriculture) have joined forces for this exciting new report. With the best expertise and a unique network to access cutting-edge information on the biocontrol and biostimulants industry segments, the 2BMonthly Team will ensure that each issue delivers the latest and most critical news directly from all stakeholders. Subscribe today for your SINGLE SOURCE of cutting-edge news from the fastest growing industries in inputs supplied to agriculture. The first issue was released on April 16, 2013. Each issue includes: • Trending Now from each Industry … Type: | 0 | 0 | 0 | 4 |
 | 3Bar Bio Activating the Power of Microbes 3Bar Biologics is a cutting-edge biotech company that helps the agricultural value chain optimize their solutions for improving quantity and quality of crop production. 3Bar’s proprietary delivery method grows fresh microbes on-site to ensure farmers have the most viable and abundant beneficial microbes at the time of application. By partnering with innovative like-minded companies and research universities, 3Bar is delivering the highest quality and most cost-effective biological microbe solutions to drive profitability for the agriculture industry, while also reducing its dependence on synthetic chemicals. Manufacturing, Innovative Packaging, Engineering, and Supply Chain Type: | 0 | 0 | 0 | 26 |
 | 3Biotech 3Biotech provides Innovative solutions continuously to create a new future and impact patient outcomes 3Biotech provides Innovative solutions continuously to challenge, support and accelerate the manufacturing of safe drug candidate. We are your colleagues, partner for the Chemistry, Manufacturing and Control (CMC) to succeed in your project and mission to create a new future and impact patient outcomes. Three Pillars; Safety, Efficacy, Manufacturing are our drivers to secure all steps from the research to the first in human stage with the most innovative project strategy and plan to execution More, we have implemented a human and customer centric organization to … Type: | 2 | 1 | 2 | 4 |
 |  3Brain AG We empower researchers to explore intelligent biological networks by linking them to information technology. 3Brain developed and distributes the world’s first commercial CMOS-based high-resolution Microelectrode Array (MEA), a Biosensor integrating thousands of tiny electrical sensors in a small area. Our Biosensor allows non-invasive (in vitro) investigations of electrogenic cells, such as neurons, cardiac and muscle cells. The technology can be used to investigate electroactive cells' fundamental properties (e.g., neural code for learning and memory), to study and find new treatments to different types of diseases (e.g. Alzheimer and epilepsy) and to assess compounds/chemical toxicity. Microelectrode Arrays, High Resolution Electrophysiology, Electrophysiology … Type: | 0 | 0 | 0 | 53 |
 | 3d.FAB platform The only French platform dedicated to academic and private innovations through 3D/4D/bioprinting in the field of health 3d.FAB platform is the only French “Plateforme Technologique Innovante” dedicated to academic and private innovations through 3D, 4D and bioprinting, in the field of life science and healthcare. The platform is suported by the @Région AURA. The platform have expertise and facilities in the following areas: - Biochemistry, especially diagnosis with prototyping 3D lab-on-chip, novel materials for 3D medical devices, biocompatible polymers and cell-size 3D printing. - Regenerative medicine through dedicated living cells and tissues printers. - Simulation to create optimal liquid flow … Type: | 8 | 3 | 5 | 12 |
 | 3P Biopharmaceuticals We are now 3PBIOVIAN! Follow us on our new LinkedIn page, 3PBIOVIAN, to stay updated on all the latest developments and news! 3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO. Read more here: www.3pbiovian.com ***** 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. Our service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production. Additionally, we provide fill and finish services for recombinant proteins and viral vectors. With a combined … Type: | 2 | 0 | 1 | 230 |
 | 4Dcell Smart control of the cell microenvironment - Bioengineered in vitro assays Experts in cell microenvironment control. At the forefront of the new challenges in biology, 4Dcell offers more reliable innovative study models, which are closer to the natural environment of the cell. 4Dcell technologies provide solutions for a myriad of applications. Among them, we highlight models for cancer, immune system, organs such as heart or gut, circulating cells, wound healing, neuronal network, stem cells and genetic disorders such as laminopathy. Years of research have led 4Dcell to develop an innovative 3D cell culture technology that enables the acquisition of more … Type: | 1 | 1 | 0 | 11 |
 | 4P-Pharma 4P-Pharma is a clinical stage biotech company founded in Lille in 2014. We focus on untreated serious diseases with high unmet medical needs, aiming to rapidly deliver effective, regenerated, first-in-class therapies. The company has developed a proprietary development engine to address the main pain points of traditional drug development: time, costs, and predictability to deliver optimized risk adjusted returns. We leverage assets with a short time to market, strong IP position, and regulatory opportunities (emergency use or conditional marketing authorizations) in blue-ocean markets. Translational research, Biotechnology, Pharmaceuticals, Inflammation, Abuse deterrent formulations, Research and Development, Drug Development, Preclinical development, Clinical development, … Type: | 5 | 2 | 3 | 30 |
 | 64x Bio An evolution in cell line engineering. High throughput engineering of cell lines to enhance the design and manufacture of next-generation therapeutics. Gene therapy, Synthetic Biology, Genome Engineering, and Functional Genomics Type: | 1 | 1 | 0 | 20 |
 |  9th Dimension Biotech, Inc. Planting the seeds of human health. PLANTING THE SEEDS OF HUMAN HEALTH. First in the world to offer the age-reversing, lifespan and healthspan enhancing Osmotin plant protein product line. Available now in the US and worldwide. Visit www.osmotin.com for more info. biotech, cell life and death cycle, plant biotechnology, human health, age-reversing, and agriculture Type: | 0 | 0 | 0 | 2 |
 | A4F-Algae for Future Confidence built on experience A4F is a biotechnology company, located in Portugal, with more than 20 years of accumulated experience in algae Research & Development and algae production (up to industrial scale). A4F is specialized in the design, build, operation and transfer (DBOT) of algae production units, from research, demonstration to industrial scale, using different technologies that better adapt to our Customers’ business. Complementing our long experience, A4F distinguishes itself through its methodology which includes scaling-up from prototypes in our Experimental Unit in Lisbon to large-scale facilities. Additionally, A4F also develops standard operating procedures for optimized algae production, according to … Type: | 2 | 1 | 0 | 60 |
 | A-Alpha Bio The protein-protein interaction company A-Alpha Bio is a biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Our experimental platform, AlphaSeq, enables the rapid and quantitative measurement of millions of protein-protein binding affinities simultaneously. Our computational platform, AlphaBind, is trained on the world’s largest protein-protein interaction database and predicts binding strength from sequence. A-Alpha Bio leverages AlphaSeq and AlphaBind for in-house therapeutic programs and in partnership with leading pharmaceutical companies to inform the discovery and development of novel therapeutics. A-Alpha Bio is based in Seattle and was founded in 2017 at the University of … Type: | 4 | 0 | 4 | 53 |
 | AATec Medical Unlocking the therapeutic potential of AAT AATec Medical GmbH is a biotech company developing a product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases, virus infections and rare diseases. The first product candidate is a novel AAT formulation for inhalation to treat emerging inflammatory diseases of the lung and respiratory virus infections. Type: | 0 | 0 | 0 | 7 |
 | Abbelight [Automatic translation follows] From Microscopy to Nanoscopy _ Scalable bioimaging solutions and multiple expertise to speed-up your imaging projects Founded in 2016, Abbelight is a fast-growing company specialized in imaging solutions focusing on microscopy and unique single molecule detection (super-resolution). The portfolio integrates a constantly evolving knowhow on chemistry, optics and computer science to offer a complete solution, from sample preparation to data management, including an optimal bio-imaging platform that can be adapted to all researchers', biotech labs' and medical facilities' needs. Abbelight is a French company developed by four passionate researchers who aim to help improve human health in … Type: | 8 | 4 | 6 | 47 |
 | abcam At Abcam, we believe the scientific community goes further, faster when we go there together. And to keep on making ground-breaking discoveries, we need to work together in new ways. That’s why we’re constantly innovating to help scientists drive their research forward by providing products and solutions that play an essential role in fundamental research, drug discovery, diagnostic and therapeutic applications. We started with a simple mission: to provide the best biological reagents to life scientists worldwide. Today, we help 750,000 researchers in over 130 countries deliver faster breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders. … Type: | 13 | 1 | 6 | 2,306 |
 | Abcell-bio Human primary cells to enhance your research Specialized in cell culture, Abcell-bio has a 10-year background and experience in Stem Cell Research and Development. Abcell-bio team is composed of experts that can advise you for your research projects. Our technical team is trained to produce high-quality products in the fields of hematopoiesis and vascular biology. We can process several cell types extracted from: * Cord Blood: CD34+ cells, CD133+ cells, CD34- cells, MonoNuclear Cells (MNCs), Endothelial Progenitor Cells (EPCs) * Umbilical Cord (Human Umbilical Vein/Arterial Endothelial Cells (HUVEC, HUAEC) We also created Cell Culture Media to match your needs for … Type: | 1 | 1 | 0 | 10 |
 | AbCellera Antibody discovery engine AbCellera discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. Antibody Discovery, Cell Culture, Antibody Therapies, Protein Analysis, Microfluidic Single Cell Analysis, Single Cell Genomics, Monoclonal Antibody Discovery, Cell Enrichment, Cell Screening, Cell Recovery, Protein engineering, T cell engagers, and Bispecifics Type: | 9 | 1 | 2 | 551 |
 | ABCT: Accelerator for Biosciences in Connecticut Supporting the development of Connecticut's hub of bioscience innovation and commercialization ABCT is a competitive entry, 6-month long program designed for entrepreneurial research students and faculty, MBA's and MD's interested to form new ventures in biosciences. ABCT encourages applications from IP based inventions. You do not need a company formed to apply to ABCT. ABCT features a mini-MBA curriculum, expert coaching, networking, mentorship, pitch preparation, access to professional colleagues as Venture Advisors from the program Corporate Supporters including Pfizer, Purdue Pharma, Boehringer Ingelheim, Microsoft, Shipman & Goodwin, WilmerHale and access to the NYC biosciences community including foundations and investors. Program … Type: | 1 | 0 | 0 | 30 |
 | ABEC engineered solutions and services for biotech manufacturing ABEC engineered solutions and services for biotech manufacturing Since 1974, ABEC has been a global leader in delivering integrated process solutions and services for manufacturing in the biopharmaceutical industry. Many of today’s leading antibody, vaccine, and recombinant protein therapies are manufactured by processes and equipment engineered, manufactured, installed and serviced by ABEC, and a majority of the world’s pharmaceutical and biotech companies are ABEC customers. ABEC’s unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether building new capacity or improving existing facilities, ABEC’s turn-key … Type: | 1 | 0 | 1 | 582 |
 | AB Enzymes Delivering the right enzyme solutions for your business success AB Enzymes is an industrial biotech company specialized in enzymes and their applications. The company is part of Associated British Foods and represented worldwide. Our offices are located in Brazil, China Germany, Finland, Singapore and USA. Our products range from food grade enzymes for baking and beverages, grains and vegetable oil seeds processing, to enzymes for animal feed and technical applications: pulp & paper, textiles and laundry detergents. We partner with our diverse and unique customers to support them in their process optimization needs. Enzymes for Baking, Detergents, Textiles, Pulp & … | 0 | 0 | 0 | 168 |
 | Abivax Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Abivax is currently evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. Abivax also plans to initiate a Phase 2a clinical trial of obefazimod in patients with Crohn’s disease. Obefazimod is an investigational, orally administered, once-daily therapy, which we believe has the potential to be a differentiated treatment option for inflammatory bowel diseases. It is the first and only molecule … Type: | 8 | 5 | 4 | 78 |
 | AbLeads AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine Type: | 0 | 0 | 0 | 1 |
 | ABLE - Association of Biotechnology Led Enterprises The Collective Face of the Indian Biotechnology Industry Association of Biotechnology Led Enterprises - ABLE is a not-for-profit pan-India forum that represents the Indian Biotechnology Sector. It was launched in April 2003, after industry leaders felt a need to form an exclusive forum to represent the Indian Biotechnology Sector. ABLE has members from all across India representing all verticals of the sector like agribiotech, bio-pharma, industrial biotech, bioinformatics, investment banks and Venture Capital firms, leading research and academic institutes and law firms and equipment suppliers. The primary focus of ABLE is to accelerate the pace of growth of the Biotechnology … Type: | 2 | 1 | 1 | 17 |
 | Abolis Biotechnologies Decipher - Innovate - Build Abolis is a French company developing high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms. Founded in 2014, Abolis is made up of a team of over 50 people, sharing a scientific and humanist ambition. Determined to become a key player in the ecological transition, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals. We help industries make … Type: | 11 | 1 | 11 | 42 |
 | Absci Creating Drugs at the Speed of Ai Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug CreationTM platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to learn, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed antibodies to wet lab-validated candidates in as little as … Type: | 7 | 0 | 8 | 184 |
 | Abyss Ingredients Natural and sustainable marine ingredients for well-being and healthy-aging Abyss Ingredients was founded in 2004 on the initiative of Brittany's fishing and fish processing professionnals who aimed at valuate marine by-products. Our R&D team works together with universities and CRO on innovation and new developments to respond to the growing demand of natural and sustainable healthy-aging solutions. The efficacy of our ingredients is scientifically proven: we heavily invest in studies to bring to our clients full solution. biotech, marine ingredients, sustainable ingredients, natural ingredients, collagen peptides, innovative peptides, nutraceutic, and nutricosmetic Type: | 4 | 2 | 3 | 20 |
 | Abzena Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, … Type: | 6 | 0 | 0 | 446 |
 | Acceleron Pharma Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases Type: | 4 | 1 | 2 | 75 |
 | AC Immune We shape the future of neurodegeneration by discovering and developing breakthrough therapies through pioneering science AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigenTM and MorphomerTM, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical … Type: | 4 | 1 | 2 | 171 |
 | ACM Global Laboratories Delivering state-of-the-art central lab services across the globe ACM Global Laboratories, an affiliate of Rochester Regional Health in Rochester, New York, is a recognized leader global clinical trial testing services. ACM Global Laboratories operates in more than 65 countries around the globe, with wholly owned facilities in the U.S.A., England, India, and Singapore. Our full-time staff of laboratory experts performs more than 20 million tests annually, spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology and more. For more information, visit www.ACMGlobalLab.com or call 1-866-405 0400 Central Laboratory Testing for Global Clinical Trials, Central Laboratory Services, Clinical Trials Testing, … Type: | 0 | 0 | 0 | 430 |
 | ACOBIOM Biomarkers & Diagnostics for Precision Medicine Acobiom is specialized in the identification of new Biomarkers and in the development of innovative Diagnostics in Translational Research and Precision Medicine. The company provides also customized services in genomics, transcriptomics, bioinformatics and biostatistics (data science), thanks to its technology platform and its scientific expertise. For more information about Acobiom, please contact the company by email: busdev@acobiom.com, or visit its website: www.acobiom.com. Biomarker, Diagnostics, Companion diagnostics, Bioinformatics, Alzheimer, Pancreatic cancer, Precision medicine, Personalized medicine, biostatistics, artificial intelligence, biomarkers, targeted therapy, cancer, data science, breast cancer, and lung cancer Type: | 2 | 2 | 1 | 7 |
 | ACQUA INNOVATION SAS [Automatic translation follows] Water is not necessary for life...it is Life!! -Antoine de St Exupery Acqua Innovation strives day after day to develop natural products in the water sector. Acqua innovation works every day to respect Man, Nature and the Environment. Indeed, we work and innovate by creating very high quality Products while respecting strict standards. Our areas of activity: - Health & Well-being => Energized mineral water in 100% vegetable bottle - Disinfection & Hygiene => Disinfection of air, premises, hand hygiene - Agriculture & Breeding => Dynamization of culture water and food, disinfection of animals and breeding sites, … Type: | 1 | 1 | 0 | 4 |
 | ACS Biotech [Automatic translation follows] The cartilage repair solution ACS Biotech Develops Innovative, Reliable, Durable Injectable Cartilage Repair Solution to Treat Cartilage Injuries Type: | 13 | 5 | 7 | 7 |
 | Acticor Biotech To treat the acute phase of ischemic stroke ! Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the … Type: | 10 | 9 | 4 | 37 |
 | Activatec Ltd Technology development, R&D, Biobased ingredients Activatec develops technologies to produce biobased ingredients from renewable sources. We are specialised in the evaluation, scale-up and commercialisation of processes to produce biotechnological and plant-based ingredients and materials from currently unused and low-value organic sources. Activatec is a B2B Partner that provides support to the industrial biotechnology sector in the form of research services on a contract basis. We are currently working within a number of international partner projects to design, develop and scale-up novel technologies for the production of emerging and high-value bio-based products. biotechnology, research and development, biotech, biobased products, bioproducts, bioingredients, … Type: | 2 | 0 | 1 | 1 |
 | Adaptive Biotechnologies Corp. Every immune system has a story to tell; the key is knowing how to listen. Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision. Working with drug developers, clinicians and academic researchers, we are applying these insights to develop products that will transform the way diseases -- such as cancer, autoimmune conditions, and infectious diseases -- are diagnosed and treated. For more information, please … Type: | 5 | 1 | 5 | 715 |
 | Adcendo ADCs, Copenhagen, Denmark. Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need. The company was founded in 2017 in Copenhagen, as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen. Type: | 0 | 0 | 0 | 42 |
 | ADC Therapeutics Innovating Science. Inspiring Hope. ADC Therapeutics is a commercial-stage biotechnology company improving the lives of those affected by cancer with our next-generation, targeted antibody drug conjugates (ADCs). With an ADC platform validated by the FDA approval of ZYNLONTA® and a deep understanding of the oncology treatment landscape, we are working to address significant unmet medical needs and improve outcomes for those with difficult-to-treat hematological cancers and solid tumors. Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in London (R&D), New Jersey (Clinical and Commercial), and the San Francisco Bay Area (CMC). Our highly skilled global team … Type: | 1 | 0 | 1 | 301 |
 | Addex Therapeutics Allosteric modulators for Human Health Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Allosteric modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecule or biological drugs. Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention. Addex's lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is poised to start a pivotal registration clinical trial … Type: | 2 | 0 | 2 | 25 |
 | Addgene A Better Way to Share Science Addgene is a nonprofit plasmid repository located in Watertown, Massachusetts. Addgene’s mission is to accelerate research and discovery by improving access to useful research materials and information. Addgene facilitates the sharing of high-quality scientific materials, research reproducibility, and open science by archiving and distributing DNA-based research reagents and associated data to scientists worldwide. Addgene’s repository contains over 70,000 plasmids, including special collections on CRISPR, fluorescent proteins, chemogenetics, optogenetics, and viral plasmids. All plasmids in Addgene’s repository were deposited by your scientific colleagues from around the world. There is no cost for scientists to deposit … Type: | 2 | 0 | 0 | 120 |
 | Adebiotech [Automatic translation follows] The think tank for Biotechnologies and One Health in France The independent Think Tank of Biotechnologies and ONE HEALTH in France, Adebiotech brings together industrial and academic experts as well as representatives of national and regional public authorities. With the largest French transdisciplinary network in life sciences, Adebiotech promotes biotechnologies and their applications in France, Europe and internationally. Adebiotech's interventions can be carried out transversally in all fields of application of biotechnologies, human and animal health, environment, energy, agri-food, industrial processes and sectors by encouraging sustainable development through the reasoned use of living techniques. Think tank biotechnologies, … Type: | 14 | 2 | 6 | 3 |
 | Ademtech [Automatic translation follows] Our innovative technology from French research (CNRS Bordeaux) makes it possible to manufacture monodisperse polymer beads (CV<20%), very magnetic (iron oxide content>70%), calibrated from 100 to 500 nm (+ /- 10 nm), offering a high specific surface area (5 to 25 m2/g). These magnetic beads are stable, sensitive and quickly separable under magnetic field. These particles are particularly well suited to be integrated into microfluidic devices. Their surface is, and can be, functionalized by the grafting of molecules of biological interest, in order to capture, isolate and separate, analyze or purify biological entities (molecules, oligonucleotides, cells, viruses) … Type: | 0 | 0 | 0 | 28 |
 | ADEQUABIO [Automatic translation follows] The science of pollution control Created in early 2018 ADEQUABIO was created following many years of scientific research and the completion of a project as part of the European Life program. The company's core business is the Production and Use of photosynthetic bacteria for the bioremediation of effluents. It markets the Phytobarre device, developed during the Life-Phytobarre project. This is a turnkey station for the treatment of agricultural effluents with photosynthetic bacteria. Also wanting to diversify its fields of activity, ADEQUABIO explores new avenues and also participates in research projects. For example, the VESPA Project which aims … | 2 | 2 | 0 | 4 |
 | AdipoPharma SAS French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and associated comorbidities AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. Our first-in-class candidate - PATAS - is set to enter clinical trials later this year. Type: | 9 | 3 | 6 | 64 |
 | AdipoPhYt It is now recognized by WHO that Obesity is an epidemic. Its pharmacological treatment remains an unmet medical need. Consumers are forced to rely on nutritional products for weight loss, with unproven efficacy. This has led the European Union to impose the scientific validation of these products, causing the convergence of the pharmaceutical and agro-food sectors. Using a proprietary innovative technology, we are dedicated to optimize and generate rapidly new proofs of clinical efficacy in Health-Nutrition for its products in order to licence them out to leading companies in the pharmaceutical and agro-food sectors. | 0 | 0 | 0 | N/A |
 | Adjuvatis Built around safe-by-design concept, Adjuvatis is committed for innovative formulations to improve pharmaceuticals Adjuvatis, a French startup in biotechnology, develops innovative safe-by-design delivery systems to help laboratories and pharmaceutical companies in vaccine formulation as adjuvants and in drug delivery as vectors for oncology, dermatology, infections, etc. Our first technology, called i-Particles®, is based on 200 nm-diameter particles composed of poly-lactic acid only (any surfactant and solvents) for formulation of hydrophobic molecules in the particle core and surface functionalization of peptides. Our second technology, i-LipoP®, consists in i-Particles® covered by lipidic bilayers at their surface for vectorization of nucleic acids and … Type: | 2 | 0 | 2 | 4 |
 | ADLIN Science Your digital partner in Life Science innovation ADLIN Science assists researchers in the management, analysis and valorization of multi-omics data. By providing a software to facilitate the generation of quality and interoperable data, ADLIN Science enables researchers to gain in scientific efficiency, to save time and to valorize economically and scientifically their data. ADLIN Science solution is based on a technical infrastructure co-developed with academic research allowing biologists, bioinformaticians and mathematicians to work within multi-disciplinary teams responding to a specific biological question. Health-tech, Logiciel, Multi-omic, Data, Société à mission, Médecine de précision, Data structuration, Data analysis, IA, Data visualization, Biostatistic, … Type: | 36 | 8 | 31 | 30 |
 | adMare BioInnovations Building Canada's life sciences industry from sea to sea With offices in Montreal, Vancouver and Toronto, adMare is building Canada’s life science industry from sea to sea. With a strong track record of globally-competitive scientific discovery, Canada is primed to lead the life sciences world. To make this a reality, at adMare BioInnovations, we use our scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems and industry-ready talent — and re-invest our returns back into the Canadian industry to ensure its long-term sustainability. www.admarebio.com Avec des bureaux situés à Montréal, Vancouver … Type: | 5 | 1 | 4 | 138 |
 | ADOCIA "Innovative medicine for everyone, everywhere" "Innovative medicine for everyone, everywhere" Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia operates in the diabetes and metabolic disease field. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients. For more information, visit our website: www.adocia.com For careers offers, please click to the following link : http://offres.adocia.com/en Therapeutic proteins, BioChaperone®, Next-generation injectables for diabetes treatment, Ultra-rapid Insulin, Multi-agents injectable combination, … Type: | 4 | 2 | 2 | 86 |
 | Advamedica Inc. Biomaterials. Hemostats. Medtech Advamedica Inc. is a deep science medtech company focused on biomaterial based medical devices. Hemostats, Woundcare, and Biomaterials Type: | 0 | 0 | 0 | 3 |
 | Advanced BioDesign Overcoming Tumor Drug Resistance Founded in 2010, Advanced BioDesign is a clinical stage company developing a highly promising therapy for cancer with high unmet medical needs. Advanced Biodesign has developed a therapeutic approach based on a selective inhibition of ALDH enzymes. Advanced Biodesign project consist in the development of small-molecule that will selectively inhibit specific ALDH enzyme. By targeting this family of enzyme, will block specifically the intracellular mechanism of detoxification that cancerous cells have developed in order to escape form the programmed cell death called apoptosis. Oncology Type: | 4 | 1 | 3 | 22 |
 | Advanced Brain Monitoring Over the past decade, Advanced Brain Monitoring has developed and implemented mobile, user-friendly platforms for acquiring, integrating, analyzing and reporting multi-sensor data in real-world applications. Our strong and growing technical team includes PhD- and masters-level hardware engineers, biostatisticians, software engineers and experts in signal processing, experimental design and clinical trials. ABM seeks to build on existing collaborations within the academic community and develop strategic partnerships across industry with like-minded professionals. Type: | 1 | 0 | 1 | 43 |
 | Advanced Solutions Life Sciences Advanced Solutions designs and manufactures robotic and vascular platforms for building human tissues. Advanced Solutions Life Sciences (ASLS) is dedicated to the discovery, design, and development of integrated software and hardware solutions for the fields of science that involve living organisms, molecular biology, and biotechnology. ASLS offers a full service business model including its patent pending BioAssemblyBot® Technology Platform, BioBot® Basic platform, TSIM® Software, VIPMTM, Professional Services and Supplies. BioTechnology, Robotics, 3D Bioprinting, 3D Software, and Biofabrication Type: | 0 | 0 | 0 | 21 |
 | Adverum Biotechnologies We are on a global mission to establish gene therapy as a new standard of care for the leading causes of vision loss. Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its … Type: | 0 | 0 | 0 | 141 |
 | AELIS FARMA A clinical stage biotech company opening a new frontier in pharmacology Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases. Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments. These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology. Two initial drug candidates are already in clinical trials … Type: | 6 | 2 | 4 | 27 |
 | AELIX Therapeutics Developing novel vaccines to cure HIV infection AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen. Type: | 2 | 1 | 1 | 6 |
 | Aenitis Technologies Acoustic Cell Processing Solution Aenitis develops and promotes devices for continuous, contactless and pressureless cells handling, using acoustic forces. Aenitis focuses on cell and gene therapy players' challenges by developing innovative cost-effective bioprocessing systems for cell sorting, cell washing, cell confinement and cell isolation. Sorting, acoustophoresis, medical devices, cells, and Bioproduction Type: | 19 | 3 | 17 | 15 |
 | Aeras Aeras is a non-profit biotech advancing the development of tuberculosis vaccines for the world. In collaboration with global partners in Africa, Asia, North America and Europe, Aeras is supporting the clinical testing of six experimental vaccines as well as a robust portfolio of earlier stage candidates. Aeras receives funding from the Bill & Melinda Gates Foundation, the UK Department for International Development, and the Netherlands’ Ministry of Foreign Affairs and a range of other governments. Aeras is based in Rockville, Maryland; Cape Town, South Africa; and Beijing, China. tuberculosis, vaccines, clinical trials, vaccine manufacturing, and HIV Type: | 1 | 0 | 1 | 63 |
 | Aether We're building the post-scarcity future. Aether’s mission is to build a future of abundance for the human race. We believe that the machinery of nature can be reverse engineered to manufacture any arrangement of atoms desired, enabling the production of new products anywhere on earth. Type: | 0 | 0 | 0 | 39 |
 | AFFICHEM [Automatic translation follows] Posterem is a medicinal chemistry company that develops innovative molecules for therapeutic purposes against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics. Posterm is a medicinal chemistry company which develops innovative therapeutic molecules against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics. Type: | 0 | 0 | 0 | 1 |
 | Affilogic Discovering and developing Nanofitins® through collaboration with worldwide pharma industry leaders Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector. These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule. Affilogic has designed Nanofitins® against 60+ targets to date, … Type: | 3 | 3 | 1 | 36 |
 | AFFiRiS AG Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you. We are a clinical-stage biotechnology company that strives to challenge established treatment options for neurodegenerative diseases in order to preserve the quality of life of patients. WE FOCUS ON UNMET MEDICAL NEEDS IN CHRONIC DISEASES Currently available treatments for many neurodegenerative diseases aim to manage symptoms, and do not stop disease progression. As a result, neurodegenerative diseases often lead to a reduced quality of life. Better treatments for these diseases are needed to give patients healthier, happier, and longer lives. We aim to develop therapeutic and … Type: | 0 | 0 | 0 | 5 |
 | AfricaBio AfricaBio is an independent, non-profit biotechnology stakeholders association. Its key role is to provide accurate information and create awareness, understanding as well as knowledge on biotechnology and biosafety in South Africa and the African region. | 3 | 1 | 2 | 17 |
 | AFTER-BIOCHEM Anaerobic FermenTation & EsteRification of BIOmass to produce at industrial scale fine CHEmicals The AFTER-BIOCHEM project is aiming to develop the first all-in-one chemical platform for creating multiple value chains based on the transformation of sugar industry's co-product as well as other non-food biomass feedstocks - into bio-based molecules and derivatives for various applications. AFTER-BIOCHEM brings together at different stages of the value chain teams 12 European partners from 5 European countries. The project will be carried out over 48 months, from May 2020 to April 2024, with an overall budget of € 33M including € 20M funding from the … | 6 | 1 | 5 | N/A |
 | AFYREN Biotech company producing biobased organic acids and derivatives via non-food biomass fermentation 🌿 AFYREN is a pioneering biotech company, developing innovative solutions for the production of high value-added biobased compounds. Our purpose is to “enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment”. Our Technology is based on a biomimetic fermentation process patented worldwide through 10 patent families 🔬 Our production model: AFYREN NEOXY, AFYREN’s first plant is a unique, low-carbon, zero-waste biorefinery that produces 7 100% biobased acids. It is located in Carling Saint-Avold (Grand-Est region, France) a strategic location set in … Type: | 70 | 21 | 54 | 107 |
 | AgBoost Data has a story to tell, we give it a voice. Agric-Bioformatics, INC is a technology company designed for the livestock industry. Our goal is to analyze, manage and improve performance and genomics data. Our cloud based Platform AgBoostTM will process and streamline data for selective breeding, health, market value and nutrition management. We aim to provide livestock producers an affordable, easy-to- use tool that allows for better access to, and understanding of, genomic information. Agric- Bioformatics will revolutionize the industry by determining market value of herd from an early age; providing for better breeding, enhanced nutrition management, and organization … Type: | 0 | 0 | 0 | 5 |
 | Age Labs AS Extending human healthspan Aging is the main cause behind most illnesses that eventually kill us. Your chance of dying doubles every 8 years. By the time you turn 80, half of your peers are dead. However, it turns out aging is a biological process, amenable to treatment. Research has demonstrated that we can postpone the onset of age-related disease. Lab mice know this already. Experiments with caloric restriction, senolytics and metabolic inhibitors have extended life and reversed aging - in mice. But how do we know these treatments will work in humans? We can wait and see if patients receiving … Type: | 0 | 0 | 0 | 5 |
 | AgenT Detect Alzheimer's earlier, when it could be prevented AgenT is a life sciences company on a mission to defeat Alzheimer’s disease by targeting the silent phase. By combining multi-omics assays with advanced machine learning techniques, we found new blood biomarkers deregulated from the earliest stages of the disease. Using this proprietary database, we are developing accurate blood diagnoses and the next generation of precision therapies to treat Alzheimer’s. ALzheimer's disease, Biotechnology, Diagnosis, Machine learning, and AI Type: | 10 | 2 | 6 | 33 |
 | Agenus Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or follow us at @agenus_bio. Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/ Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing Type: | 1 | 0 | 1 | 297 |
 | AgeRate Unlocking the secret to living a longer and healthier life. AgeRate provides a mobile app + blood test that allows you to monitor how well you are aging, so you can make the right lifestyle choices sooner to be healthier for longer and conquer aging. Type: | 0 | 0 | 0 | 6 |
 | AgeX Therapeutics, Inc. AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. AgeX Therapeutics, Inc. (“AgeX”) is a biotechnology company focused on the emerging field of interventional gerontology. Its technology platform is built upon a modern understanding of the molecular basis of cellular immortality and regenerative biology. Leveraging technology licensed from parent company BioTime, Inc. as well as Geron Corporation, AgeX is leading the development of novel therapeutics targeting some of the largest market opportunities associated with an aging population. Type: | 0 | 0 | 0 | 12 |
 | Aggressively Organic, A Public Benefits Corporation. Our mission is to end food insecurity by designing sustainable Hydroponic, Aquaponics, Gardening and Agricultural systems accessible to all. Organic Food, Hyrdoponics, Natural Foods, Gardening, and Sustainability Type: | 0 | 0 | 0 | 3 |
 | Agilent Technologies Let’s Bring Great Science to Life. Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s … Type: | 15 | 2 | 0 | 17,239 |
 | Agoprene We’ll get rid of oil based foam. We produce biofoam from seaweed to get rid of oil based foam. Get in touch: https://www.agoprene.com/get-in-touch Type: | 3 | 0 | 2 | 6 |
 | Agri-Neo Helping Safely Feed the World Agri-Neo is an innovative food safety technology company. We are proud to be named one of Canada’s Top Growing Companies by The Report on Business, and one of the top five food safety companies in North America by FoodTech 500. We help food companies protect their brands, comply with regulations, and become industry leaders by providing them with our solutions to achieve the highest in food safety standards. We are always looking to connect with people who are passionate about making a difference in the world and who could join our team to help Agri-Neo … | 0 | 0 | 0 | 38 |
 | AgriProtein Harnessing the power of insects and technology to produce valuable, sustainable products using existing organic waste. AgriProtein is leading a new industry called nutrient upcycling. Our mission is to close the loop in food production. We use our technology to leverage the natural capabilities of the black soldier fly; feeding its larvae existing organic waste to create a sustainable, natural protein for pets, livestock and fish. Our industrial-scale bioconversion process takes organic waste streams from food factories, supermarkets, farms and restaurants, and recycles these into valuable products including: an insect based complete protein (MagMealTM), a versatile, natural oil (MagOilTM) and … Type: | 3 | 1 | 2 | 44 |
 | Agro-Bio The future is in the genes. Agro-Bio is a non-profit organization, founded in 2000, dedicated to promoting, disseminating, educating, and informing everything that has to do with modern agricultural biotechnology and genetically modified organisms in countries of the Andean region (Colombia, Ecuador, Perú, and Venezuela). Biotecnología, Cultivos, Agricultura, and BioTech Ag Type: | 0 | 0 | 0 | 13 |
 | Agro-Bio Antibodies Our specificity, your antibodies Pioneer in antibodies’ field, Agro-Bio provides you its expertise and its know-how for production, development and characterization of antibodies. For over 40 years, our team supports pharmaceutical and in vitro diagnostic industries as well as public institutions for their immunology issues. We collaborate both to offer you the most suitable and effective solution. Our goal is the success of your projects. Our services around antibody: • Bioanalysis/Biopharma: o Anti-idiotypic antibodies for positive control, PK and potency test, o Host Cell Protein issue management: specific anti-HCP antibodies, 2D Western Blot coverage analysis, specific ELISA kit, o Epitope … Type: | 0 | 0 | 0 | 48 |
 | AgroFresh Empowering the business of fresh at every step. Empowering the business of fresh at every step. At AgroFresh, that’s what we do—day in and day out. AgroFresh empowers you to succeed in the business of fresh produce by providing science-based, data-driven post-harvest solutions across the supply chain that enhance the quality and shelf-life of fresh produce, prevent food loss/waste and preserve the planet’s resources. We provide the resources you expect from a post-harvest leader with the purpose of helping our customers deliver abundant, sustainable, quality produce for all. We put innovation in motion. We believe the most exciting innovations are … Type: | 1 | 0 | 0 | 587 |
 | AgroGrIN Tech "Sustainable solutions for a sustainable world" AgroGrIN Tech upcycles fruit and vegetable waste, losses and by-products into new, clean-label ingredients for industries. The AGT products fulfil the market needs of the food, nutraceutical and cosmetic industries with a full range of functional and technological ingredients. AgroGrIN Tech upcycles 100% of by-products into 100% of value since we are a ZERO waste approach company! Sustainable food, Food waste management, Upcycling, Functional foods, Food technology, Plant-based, Functional ingredients, Super foods, and Fruit and veggies upcycling Type: | 0 | 0 | 0 | 11 |
 | Agronutris A sustainable world fed and preserved through bioconversion Agronutris is the first French biotech company dedicated to the development of the insect rearing industry as an answer to the feed challenges of tomorrow. We believe that insects are an innovative and sustainable solution to face the environmental, social and societal issues of our society. Our mission is to feed and preserve the world. Insects are able to turn by-products from the agro industry into valuable ingredients for the feed market, contributing in that way to the development of a circular economy. Moreover, while the growing world population needs an increasing … Type: | 23 | 7 | 21 | 77 |
 | AgroSpheres A Future Built By Nature’s Technologies AgroSpheres is transforming agriculture through reliable and affordable biobased solutions. Biotechnology and Biological Engineering Type: | 8 | 2 | 2 | 26 |
 | AgroSustain SA AgroSustain – a one-stop-shop solution for biological plant protection. AgroSustain – a one-stop-shop solution for biological plant protection. We aim to reduce food waste and support organic food production by developing farm to fork solutions, like biological fungicides and coatings. AgroSustain has developed a pipeline of plant-derived antifungal compounds against broad range of agronomically important fungal pathogens present in pre- (in the field) and post-harvest (in storage). AgroSustain’s first product, called AgroShelf+, extends shelf life of vegetables & fruits infected with mostly spread molds. AgroSustain’s B2B customers, food distributors & producers with post-harvest storage facilities, that value more the effectiveness … Type: | 4 | 2 | 1 | 11 |
 | Agrounik [Automatic translation follows] Science dedicated to nature. We are a family company founded in 2002. Our mission to engage in research in the field of biotechnology, development of new products and active substances, production, distribution and sale of microbiological preparations with application in agricultural production and environmental protection research and development, biotechnology, microbiology, sales network, research and scientific projects, producer of microbiological fertilizers, and agriculture | 0 | 0 | 0 | 19 |
 | AgStart Accelerating Innovation in Ag|Food|Health When it comes to getting your ag/food/health innovation from proof of concept to commercialization, many startups are overwhelmed by the logistics. AgStart helps ag/food/health startups by simplifying the process and provides access to a wealth of resources so they can get their world-changing technologies funded and out into the world. Situated in the heart of Ag Innovation, AgStart knows the logistics of creating profitable ag/food/health startups and has the industry connections and know-how to de-risk the process so you can get to work faster and spend less money. Since 2021 we have helped 12 resident companies … Type: | 1 | 0 | 1 | 2 |
 | AGTC Visionary science for life-changing cures. AGTC is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe diseases, with an initial focus in ophthalmology. AGTC's lead product candidates are designed to treat inherited orphan diseases of the eye, caused by mutations in single genes that significantly affect visual function and currently lack effective medical treatments. AGTC's product pipeline includes six named ophthalmology development programs across five targets (X-linked retinoschisis (XLRS), X-linked retinitis pigmentosa (XLRP), achromatopsia, wet age-related macular degeneration and blue cone monochromacy), two non-ophthalmology programs (alpha-1 … Type: | 1 | 1 | 1 | 118 |
 | Ag-West Bio We grow biobusiness in Saskatchewan. Ag-West Bio is Saskatchewan’s bioscience industry association and bioeconomy catalyst. Our mandate is "To provide leadership, as a catalyst, to link existing capabilities and resources in order to strengthen the bioeconomy industry in Saskatchewan." Since 1989, we have been helping move research to market and grow biobusiness in the province. A not-for-profit and membership-based company, Ag-West Bio members include public research institutions, private companies (from start-ups to multinationals), research service organizations, economic development and commodity groups. Members represent biotechnology, bioproducts and biofuels, environment, health and nutrition sectors. Entrepreneurs come to Ag-West Bio for pathfinding and … Type: | 0 | 0 | 0 | 17 |
 | Aidian Aidian develops, manufactures and markets diagnostic tests and test solutions. We are a leading Finnish-based in vitro diagnostics (IVD) company established in 1974. We develop, manufacture, and distribute reliable and fast diagnostic tests for point of care. Our aim is to aid global health by promoting efficient healthcare through accurate and fast diagnostics. We provide solutions to fight against antimicrobial resistance (AMR), one of the biggest threats to global health, and drive sustainable use of antibiotics in primary care. Testing before prescribing using fast and accurate point of care tests guides rational antibiotic prescribing. High-quality products and patient safety are … Type: | 1 | 1 | 0 | 190 |
 | AIHA Laboratory Accreditation Programs, LLC AIHA Laboratory Accreditation Programs (AIHA LAP) is a group of laboratory accreditation programs. The primary mission of AIHA LAP is to establish high standards of performance for laboratories that promote the production of quality data for use in evaluating exposures that impact public health, the environment and natural resources. These programs are administered in a non-discriminatory manner and are open to all laboratories wishing to participate. Access to AIHA LAP programs is not conditional upon the size of the laboratory or organization seeking accreditation, nor are there undue financial conditions to restrict participation. Accreditation is granted to any laboratory satisfying … Type: | 0 | 0 | 0 | 11 |
 | AIHERD The Intelligent System that Cares for You and Your Animals 🐮🚀💚 🚀 Welcome to the world of AIHERD, the Nantes gem that will ignite your farmer's heart with a bold and innovative vision! 💡🐮 At AIHERD, we've gathered the brightest minds in the field: a dynamic team of passionate veterinarians, AI geniuses, and outstanding management specialists, all working in close collaboration with the prestigious CEA. Together, we form an explosive cocktail to revolutionize agriculture and pamper our adorable four-legged cows! 🌾💚 Our secret? Real-time visual analysis of bovine farms, powered by our cutting-edge artificial intelligence algorithms! 🐄💻 Imagine a world … Type: | 40 | 8 | 18 | 14 |
 | Aimmune Therapeutics POWER OVER FOOD ALLERGIES Aimmune Therapeutics, Inc., a Nestlé Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies. With a mission to improve the lives of people with food allergies, Aimmune is developing and commercializing oral treatments for potentially life-threatening food allergies. The Company’s Characterized Oral Desensitization ImmunoTherapy (CODITTM) approach is intended to provide meaningful levels of protection against allergic reactions resulting from accidental exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune has one FDA-approved medicine for peanut allergy and other investigational therapies in development to … Type: | 1 | 1 | 0 | 152 |
 | ÄIO Future-shaping fats and oils We are ÄIO and our mission is to change the way we produce, consume and perceive foods and other products. On the oil drop level. By recognising the full worth of microbial oils, we deliver tailored solutions for industries such as food, feed and cosmetics. We plan to be the largest biotech company in the Baltics, but baby steps... We were officially founded in January 2022. How do we plan to do it? Simple: we use locally available by-products to "brew" fats & oils. By-products such as forestry residues and food industry side streams. Our products … Type: | 2 | 1 | 1 | 11 |
 |  AIOVA [Automatic translation follows] Vaccines for the future Based on innovative, patented technology, AIOVA aims to develop and market innovative vaccines, with high added value, to its pharmaceutical industrial clients. AIOVA is positioned in the fight against emerging or re-emerging and deadly pandemics of humans and animals, in a OneHealth approach, and in particular influenza (human and avian influenza), AIDS-type diseases, and, very recently , diseases caused by coronaviruses such as SARS-CoV-2, responsible for the current COVID-19 pandemic. The vaccines are designed using a patented DNA platform and have the properties of activating, in the vaccinated host, not only the production … Type: | 0 | 0 | 0 | 1 |
 | Aitia Leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs Aitia is the leader in the development and application of Causal AI and Digital Twins to discover the next generation of therapies for neurodegenerative diseases and Oncology. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden circuitry of human biology to identify novel targets driving disease and focused patient recruitment for clinical development. Aitia has translated those insights into its Gemini Digital Twins (computational representations of disease), which the company is … Type: | 14 | 3 | 10 | 89 |
 | Ajinomoto Bio-Pharma Services The Power to Make Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet … Type: | 0 | 0 | 0 | 775 |
 | Akamis Bio Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer Akamis is a clinical-stage oncology company whose mission is to leverage its groundbreaking T-SIGn® platform to positively impact the lives of people living with cancer. We are developing a portfolio of solid tumor-targeted T-SIGn® therapeutics which aim to enable a patient’s own immune system to recognize, attack, and clear their cancer. Akamis’ growing pipeline of T-SIGn® therapeutics is anchored by its lead clinical-stage program, NG-350A, which is being investigated in an ongoing Phase 1 clinical study in patients with metastatic or advanced epithelial tumors. … Type: | 4 | 1 | 2 | 59 |
 | Aker BioMarine ASA Aker BioMarine ASA is a biotech and Antarctic krill harvesting company dedicated to improving human and planetary health Aker BioMarine is a biotech innovator and Antarctic krill harvesting company dedicated to improving human and planetary health. The company develops krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and all the way to customers around the world. Aker BioMarine is fully owned by Aker ASA, an industrial pioneer since its establishment in 1841. Omega-3, Krill, Biotech, and … Type: | 3 | 1 | 3 | 322 |
SMB